Jb Capital LLC Astrazeneca PLC Transaction History

Jb Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	BUY	$59.26 - $71.14 $8,414 - $10,101	142 Added 1.77%	8,151 $539,000
Q1 2022 Apr 19, 2022	SELL	$55.72 - $67.12 $56,054 - $67,522	-1,006 Reduced 11.16%	8,009 $532,000
Q4 2021 Feb 02, 2022	BUY	$54.02 - $63.83 $4,105 - $4,851	76 Added 0.85%	9,015 $525,000
Q3 2021 Dec 08, 2021	BUY	$55.56 - $60.79 $496,650 - $543,401	8,939 New	8,939 $537,000

1,352

478M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $225B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Jb Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Jb Capital LLC with notifications on news.